<DOC>
	<DOC>NCT01497132</DOC>
	<brief_summary>The purpose of this study is to evaluate if treatment with vitamin D increase beta cell function and insulin sensitivity in subjects with pre-diabetes or newly diagnosed diabetes mellitus type 2.</brief_summary>
	<brief_title>Effects of Vitamin D on Beta Cell Function and Insulin Sensitivity in Pre-diabetes and Diabetes Mellitus Type 2</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Meeting criteria for IFG, IGT, IFG+IGT or diabetes mellitus at OGTT. BMI ≤ 32 kg/m2. HbA1c ≤ 7.0 % (MonoS) or ≤ 63 mmol/mol (IFCC). Fasting plasma glucose &lt; 9 mmol/l S25OHvitamin D3 &lt; 75 nmol/l. Treatment with any vitamin D preparation. Regular sunbathing in solarium. Hypercalcemia at screening, defined as free scalcium &gt; 1.35 mmol/l. Hyperphosphatemia at screening, defined as sphosphate &gt; 1.5 mmol/l. Sarcoidosis or other granulomatous disease. Treatment with phenytoin, barbiturates, rifampicin, isoniazid, cardiac glycosides, orlistat or colestyramin. Impaired hepatic function. Impaired renal function Cardiac disease defined as: Unstable angina pectoris Myocardial infarction within the last 6 months Congestive heart failure NYHA class III and IV Cerebral stroke within the last 6 months. Antidiabetic medication of any kind. Females of childbearing potential who are pregnant, breastfeeding or intend to become pregnant or are not using adequate contraceptive methods.</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>